These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 25190513)
1. Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure. Mann JK; Chopera D; Omarjee S; Kuang XT; Le AQ; Anmole G; Danroth R; Mwimanzi P; Reddy T; Carlson J; Radebe M; Goulder PJR; Walker BD; Abdool Karim S; Novitsky V; Williamson C; Brockman MA; Brumme ZL; Ndung'u T Virology; 2014 Nov; 468-470():214-225. PubMed ID: 25193656 [TBL] [Abstract][Full Text] [Related]
2. Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women. Penrose KJ; Richardson BA; Besson G; Dezzutti CS; Herold BC; Abdool Karim SS; Mellors JW; Parikh UM; Sex Transm Dis; 2014 Nov; 41(11):674-9. PubMed ID: 25299415 [TBL] [Abstract][Full Text] [Related]
5. The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier. Lemos MP; Lama JR; Karuna ST; Fong Y; Montano SM; Ganoza C; Gottardo R; Sanchez J; McElrath MJ PLoS One; 2014; 9(9):e108954. PubMed ID: 25268493 [TBL] [Abstract][Full Text] [Related]
6. The role of specialized hospital units in infection and mortality risk reduction among patients with hematological cancers. Carmen R; Yom-Tov GB; Van Nieuwenhuyse I; Foubert B; Ofran Y PLoS One; 2019; 14(3):e0211694. PubMed ID: 30893320 [TBL] [Abstract][Full Text] [Related]
7. The mechanistic analysis of founder virus data in challenge models. Ortega-Villa AM; Nason MC; Follmann D Stat Med; 2021 Sep; 40(20):4492-4504. PubMed ID: 34111904 [TBL] [Abstract][Full Text] [Related]
8. A discrete-time survival model with random effects for designing and analyzing repeated low-dose challenge experiments. Kang C; Huang Y; Miller CJ Biostatistics; 2015 Apr; 16(2):295-310. PubMed ID: 25190513 [TBL] [Abstract][Full Text] [Related]
9. A method to address between-subject heterogeneity for identification of principal surrogate markers in repeated low-dose challenge HIV vaccine studies. Spieker AJ; Huang Y Stat Med; 2017 Nov; 36(25):4071-4080. PubMed ID: 28758224 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques. Butler K; Morgan JS; Hanson DL; Adams D; Garcia-Lerma JG; Heneine W; Ellenberger D; Hendry RM; McNicholl J; Johnson WE; Kersh EN AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1091-4. PubMed ID: 23461569 [TBL] [Abstract][Full Text] [Related]
11. Statistical design and analysis of controlled human malaria infection trials. Tian X; Janes HE; Kublin JG Malar J; 2024 May; 23(1):133. PubMed ID: 38702775 [TBL] [Abstract][Full Text] [Related]
12. Current advances in HIV vaccine preclinical studies using Macaque models. Liang B; Li H; Li L; Omange RW; Hai Y; Luo M Vaccine; 2019 Jun; 37(26):3388-3399. PubMed ID: 31088747 [TBL] [Abstract][Full Text] [Related]